ID   Y1264_MYCTU             Reviewed;         397 AA.
AC   P9WMU9; L0T7S0; Q11055;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   07-APR-2021, entry version 36.
DE   RecName: Full=pH-sensitive adenylate cyclase Rv1264;
DE            EC=4.6.1.1;
DE   AltName: Full=ATP pyrophosphate-lyase;
DE   AltName: Full=Adenylyl cyclase;
GN   OrderedLocusNames=Rv1264; ORFNames=MTCY50.18c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   INDUCTION BY HYPOXIA.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11416222; DOI=10.1073/pnas.121172498;
RA   Sherman D.R., Voskuil M., Schnappinger D., Liao R., Harrell M.I.,
RA   Schoolnik G.K.;
RT   "Regulation of the Mycobacterium tuberculosis hypoxic response gene
RT   encoding alpha -crystallin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7534-7539(2001).
RN   [3]
RP   CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND MUTAGENESIS OF ASP-107; ARG-132;
RP   ASP-222; LYS-261; ASP-265; ASP-312; ASN-319 AND ARG-323.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11839758; DOI=10.1074/jbc.m200235200;
RA   Linder J.U., Schultz A., Schultz J.E.;
RT   "Adenylyl cyclase Rv1264 from Mycobacterium tuberculosis has an
RT   autoinhibitory N-terminal domain.";
RL   J. Biol. Chem. 277:15271-15276(2002).
RN   [4]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [5]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=17005450; DOI=10.1016/j.ijmm.2006.07.001;
RA   Dittrich D., Keller C., Ehlers S., Schultz J.E., Sander P.;
RT   "Characterization of a Mycobacterium tuberculosis mutant deficient in pH-
RT   sensing adenylate cyclase Rv1264.";
RL   Int. J. Med. Microbiol. 296:563-566(2006).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF ACTIVE OR INACTIVE FORMS,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MUTAGENESIS OF HIS-192;
RP   193-MET--MET-194; GLU-195 AND ARG-309.
RX   PubMed=15890882; DOI=10.1126/science.1107642;
RA   Tews I., Findeisen F., Sinning I., Schultz A., Schultz J.E., Linder J.U.;
RT   "The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme.";
RL   Science 308:1020-1023(2005).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-207, LINKER SEGMENT, FATTY ACID
RP   BINDING, AND MUTAGENESIS.
RX   PubMed=17482646; DOI=10.1016/j.jmb.2007.04.013;
RA   Findeisen F., Linder J.U., Schultz A., Schultz J.E., Brugger B.,
RA   Wieland F., Sinning I., Tews I.;
RT   "The structure of the regulatory domain of the adenylyl cyclase Rv1264 from
RT   Mycobacterium tuberculosis with bound oleic acid.";
RL   J. Mol. Biol. 369:1282-1295(2007).
CC   -!- FUNCTION: Catalyzes the formation of the second messenger cAMP.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP = 3',5'-cyclic AMP + diphosphate; Xref=Rhea:RHEA:15389,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58165; EC=4.6.1.1;
CC         Evidence={ECO:0000269|PubMed:11839758};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:11839758};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:11839758};
CC       Note=The isolated catalytic domain prefers Mn(2+) over Mg(2+) as a
CC       cofactor. {ECO:0000269|PubMed:11839758};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=420 nmol/min/mg enzyme {ECO:0000269|PubMed:15890882};
CC         Note=At pH 6.0.;
CC       pH dependence:
CC         Optimum pH is 6.0. {ECO:0000269|PubMed:15890882};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11839758,
CC       ECO:0000269|PubMed:15890882}.
CC   -!- INDUCTION: A possible member of the dormancy regulon. Induced in
CC       response to reduced oxygen tension (hypoxia). It is hoped that this
CC       regulon will give insight into the latent, or dormant phase of
CC       infection. {ECO:0000269|PubMed:11416222}.
CC   -!- DOMAIN: Consists of 3 structural domains. The pH-responsive N-terminus
CC       inhibits the adenylyl cyclase (AC) activity of the C-terminal catalytic
CC       domain. The length of the linker segment (aa 192-206) is decisive for
CC       regulation.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype following infection of SPF
CC       C57BL/6 mice. {ECO:0000269|PubMed:17005450}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC   -!- MISCELLANEOUS: Binds 1 C18:1 fatty acid per monomer.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP44020.1; -; Genomic_DNA.
DR   PIR; H70753; H70753.
DR   RefSeq; NP_215780.1; NC_000962.3.
DR   RefSeq; WP_003406372.1; NZ_NVQJ01000049.1.
DR   PDB; 1Y10; X-ray; 2.30 A; A/B/C/D=1-397.
DR   PDB; 1Y11; X-ray; 3.30 A; A=1-397.
DR   PDB; 2EV1; X-ray; 1.60 A; A/B=1-207.
DR   PDB; 2EV2; X-ray; 2.35 A; A/B=1-207.
DR   PDB; 2EV3; X-ray; 2.68 A; A/B=1-207.
DR   PDB; 2EV4; X-ray; 2.28 A; A/B=1-207.
DR   PDBsum; 1Y10; -.
DR   PDBsum; 1Y11; -.
DR   PDBsum; 2EV1; -.
DR   PDBsum; 2EV2; -.
DR   PDBsum; 2EV3; -.
DR   PDBsum; 2EV4; -.
DR   SMR; P9WMU9; -.
DR   STRING; 83332.Rv1264; -.
DR   iPTMnet; P9WMU9; -.
DR   PaxDb; P9WMU9; -.
DR   GeneID; 887035; -.
DR   KEGG; mtu:Rv1264; -.
DR   TubercuList; Rv1264; -.
DR   eggNOG; COG2114; Bacteria.
DR   OMA; FEWSFAG; -.
DR   PhylomeDB; P9WMU9; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0004016; F:adenylate cyclase activity; IDA:MTBBASE.
DR   GO; GO:0010855; F:adenylate cyclase inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IDA:MTBBASE.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0009268; P:response to pH; IDA:MTBBASE.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR032026; Ad_Cy_reg.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16701; Ad_Cy_reg; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; cAMP biosynthesis; Lipid-binding;
KW   Lyase; Magnesium; Manganese; Metal-binding; Nucleotide-binding;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:21969609"
FT   CHAIN           2..397
FT                   /note="pH-sensitive adenylate cyclase Rv1264"
FT                   /id="PRO_0000074131"
FT   DOMAIN          217..325
FT                   /note="Guanylate cyclase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   REGION          2..191
FT                   /note="Regulatory domain"
FT   REGION          192..206
FT                   /note="Linker"
FT   REGION          211..397
FT                   /note="Catalytic domain"
FT   METAL           222
FT                   /note="Manganese or magnesium"
FT                   /evidence="ECO:0000305"
FT   METAL           265
FT                   /note="Manganese or magnesium"
FT                   /evidence="ECO:0000305"
FT   BINDING         261
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305"
FT   BINDING         298
FT                   /note="ATP"
FT                   /evidence="ECO:0000305"
FT   BINDING         312
FT                   /note="Substrate"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0007744|PubMed:21969609"
FT   MUTAGEN         107
FT                   /note="D->A: 7-fold increase in holoenzyme adenylyl cyclase
FT                   activity at pH 8.0."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         132
FT                   /note="R->A: No change in holoenzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         192
FT                   /note="H->A: Shifts activation towards acidic pH."
FT                   /evidence="ECO:0000269|PubMed:15890882"
FT   MUTAGEN         192
FT                   /note="H->E: Higher activity above pH 7.0."
FT                   /evidence="ECO:0000269|PubMed:15890882"
FT   MUTAGEN         193..194
FT                   /note="MM->PP: Loss of pH regulation."
FT                   /evidence="ECO:0000269|PubMed:15890882"
FT   MUTAGEN         195
FT                   /note="E->A: Partially relieves high pH inhibition."
FT                   /evidence="ECO:0000269|PubMed:15890882"
FT   MUTAGEN         222
FT                   /note="D->A: Loss of adenylyl cyclase activity in the
FT                   catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         261
FT                   /note="K->A: Almost complete loss of adenylyl cyclase
FT                   activity in the catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         265
FT                   /note="D->A: Loss of adenylyl cyclase activity in the
FT                   catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         309
FT                   /note="R->A: Obviates pH regulation."
FT                   /evidence="ECO:0000269|PubMed:15890882"
FT   MUTAGEN         312
FT                   /note="D->A: Loss of adenylyl cyclase activity in the
FT                   catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         319
FT                   /note="N->A: Almost complete loss of adenylyl cyclase
FT                   activity in the catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   MUTAGEN         323
FT                   /note="R->A: Retains 10% adenylyl cyclase activity in the
FT                   catalytic fragment."
FT                   /evidence="ECO:0000269|PubMed:11839758"
FT   HELIX           13..17
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           22..37
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           42..47
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   STRAND          48..50
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           51..53
FT                   /evidence="ECO:0007744|PDB:2EV2"
FT   HELIX           54..59
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           69..76
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           80..90
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   STRAND          93..95
FT                   /evidence="ECO:0007744|PDB:2EV4"
FT   HELIX           105..111
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           114..119
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           124..153
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           160..194
FT                   /evidence="ECO:0007744|PDB:2EV1"
FT   HELIX           201..205
FT                   /evidence="ECO:0007744|PDB:1Y11"
FT   STRAND          214..223
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   HELIX           226..229
FT                   /evidence="ECO:0007744|PDB:1Y11"
FT   TURN            230..232
FT                   /evidence="ECO:0007744|PDB:1Y11"
FT   HELIX           235..252
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          258..263
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          266..273
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   HELIX           274..289
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          292..294
FT                   /evidence="ECO:0007744|PDB:1Y11"
FT   STRAND          297..309
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          312..315
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   HELIX           316..327
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          333..336
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   HELIX           337..341
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          353..360
FT                   /evidence="ECO:0007744|PDB:1Y10"
FT   STRAND          369..375
FT                   /evidence="ECO:0007744|PDB:1Y10"
SQ   SEQUENCE   397 AA;  42232 MW;  F6C212A181DB5AD3 CRC64;
     MTDHVREADD ANIDDLLGDL GGTARAERAK LVEWLLEQGI TPDEIRATNP PLLLATRHLV
     GDDGTYVSAR EISENYGVDL ELLQRVQRAV GLARVDDPDA VVHMRADGEA AARAQRFVEL
     GLNPDQVVLV VRVLAEGLSH AAEAMRYTAL EAIMRPGATE LDIAKGSQAL VSQIVPLLGP
     MIQDMLFMQL RHMMETEAVN AGERAAGKPL PGARQVTVAF ADLVGFTQLG EVVSAEELGH
     LAGRLAGLAR DLTAPPVWFI KTIGDAVMLV CPDPAPLLDT VLKLVEVVDT DNNFPRLRAG
     VASGMAVSRA GDWFGSPVNV ASRVTGVARP GAVLVADSVR EALGDAPEAD GFQWSFAGPR
     RLRGIRGDVR LFRVRRGATR TGSGGAAQDD DLAGSSP
//
